ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,731Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 36

$783K Total Retail Price of All Prescriptions

Rank: 7 out of 36

418 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 418 patients filled at least one prescription for a schedule two drug, compared to an average of 11%.

Schedule Three
Controlled Substances

5% of this provider’s 418 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

0% of this provider’s 10,901 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
AMLODIPINE BESYLATE 491 463 1 2
SIMVASTATIN 447 387 2 1
LEVOTHYROXINE SODIUM 384 350 3 3
FUROSEMIDE 366 334 4 4
ATORVASTATIN CALCIUM 343 311 5 13
OMEPRAZOLE 262 243 6 6
DONEPEZIL HCL 254 251 7 10
METOPROLOL TARTRATE 247 189 8 8
WARFARIN SODIUM 240 201 9 5
NAMENDA 201 201 10 12
LEVOFLOXACIN 189 164 11 68
GABAPENTIN 184 150 12 20
CLOPIDOGREL 178 171 13 30
GLIPIZIDE 175 148 14 69
MIRTAZAPINE 174 164 15 16
LISINOPRIL 165 143 16 7
SERTRALINE HCL 156 143 17 15
ZOLPIDEM TARTRATE 154 153 18 25
NEXIUM 154 116 18 35
RISPERIDONE 143 140 20 28
METFORMIN HCL 143 101 20 9
TRAMADOL HCL-ACETAMINOPHEN 142 136 22 76
PLAVIX 141 137 23 42
LOSARTAN POTASSIUM 138 137 24 26
METOPROLOL SUCCINATE 133 109 25 11
TAMSULOSIN HCL 130 105 26 23
ENALAPRIL MALEATE 130 118 26 24
CLOTRIMAZOLE-BETAMETHASONE 111 88 28 79
MELOXICAM 109 76 29 63
DIOVAN 106 103 30 36
LIPITOR 105 90 31 78
LIDODERM 104 103 32 41
ESCITALOPRAM OXALATE 103 89 33 22
FENTANYL 102 79 S2 34 43
ALBUTEROL SULFATE 102 93 34 40
CARVEDILOL 100 100 36 21
PRAVASTATIN SODIUM 100 100 36 37
DIGOXIN 97 93 38 46
LEVETIRACETAM 97 54 38 49
ALENDRONATE SODIUM 95 88 40 33
FLUTICASONE PROPIONATE 93 76 41 60
DIVALPROEX SODIUM 86 63 42 34
ATENOLOL 86 71 42 18
ADVAIR DISKUS 83 71 44 45
PAROXETINE HCL 79 77 45 57
FAMOTIDINE 79 79 45 17
POTASSIUM CHLORIDE 78 70 47 19
TRAMADOL HCL 78 76 47 39
OXYCODONE-ACETAMINOPHEN 76 62 S2 49 29
PANTOPRAZOLE SODIUM 76 63 49 32
FOSINOPRIL SODIUM 72 69 51 218
HYDROCHLOROTHIAZIDE 67 63 52 14
LACTULOSE 67 51 52 27
SPIRIVA 66 63 54 73
EXELON 66 62 54 48
QUETIAPINE FUMARATE 66 59 54 38
PROCRIT 61 61 57 145
JANUVIA 60 57 58 47
SINGULAIR 60 52 58 94
LANTUS SOLOSTAR 58 27 60 101
ALLOPURINOL 58 29 60 59
PROAIR HFA 55 44 62 110
CARBIDOPA-LEVODOPA 55 53 62 71
AMIODARONE HCL 50 50 64 260
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 29, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.